AI Article Synopsis
- Cardiac toxicity from Pheniramine is rarely reported, but this case shows a 22-year-old developed adenosine-resistant supraventricular tachycardia (SVT) after taking it for a bean allergy.
- The link between therapeutic doses of Pheniramine and symptomatic SVT is not well established, indicating a need for more awareness among healthcare providers.
- This situation underscores the importance of thorough drug evaluations in emergencies and personalized treatment decisions for patients admitted to emergency units.
Article Abstract
Cardiac toxicity is a very seldom documented side effect of Pheniramine. Although second-generation antihistamines such as terfenadine and astemizole have been linked to cardiac injury, the incidence of SVT after Pheniramine treatment on adult clinical dose is currently unknown. In this case, we present a 22-year-old girl who developed adenosine-resistant supraventricular tachycardia (SVT) after being given pheniramine due to a bean allergy. It is crucial to know that symptomatic SVT could occur with therapeutic doses of pheniramine. This case highlights the importance of a comprehensive drug evaluation in emergency situations to identify the underlying etiologies and prompt treatment commencement. It also emphasizes the significance of assessing and choosing acute drugs for each patient admitted to the emergency unit to ensure the start of a newer medication if necessary.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121280 | PMC |
| http://dx.doi.org/10.1016/j.amsu.2022.103621 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!